Abstract
Objectives: To define the clinical association of serum prestin autoantibodies and their impact on prognosis, as specific serum diagnostic markers in patients with idiopathic sudden sensorineural hearing loss (ISSNHL). Design: Sera from 63 patients with ISSNHL were screened prospectively for the presence of prestin autoantibodies by an enzyme-linked immunosorbent assay (Elisa) test. Serum was assayed for anti-prestin IgG antibodies using recombinant human prestin (SLC26 A5). Demographic, clinical, and audiometric variables were analyzed. Results: Two patients (3.17%) had demonstrable anti-prestin antibodies in serum (exact 95% CI: −1.16% to 7.5%). No statistically significant association was found between prestin autoantibodies and demographic or audiologic parameters. Conclusions: This preliminary and novel study does not support the presence of an active humoral immune reaction against prestin in ISSNHL.
Original language | English |
---|---|
Pages (from-to) | 99-101 |
Number of pages | 3 |
Journal | European Annals of Otorhinolaryngology, Head and Neck Diseases |
Volume | 136 |
Issue number | 2 |
DOIs | |
State | Published - Apr 2019 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2018 Elsevier Masson SAS
Keywords
- Anti-prestin
- Autoantibodies
- Elisa
- Prestin
- Sudden sensorineural hearing loss